BS

Brian Sullivan

North America, Minnesota, United States, Minneapolis

Description

Brian Sullivan has served as a director of the Company since the Merger in 2005. He served as a director of Entegris Minnesota and as a memb...

Investor Profile

Brian Sullivan has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Health Diagnostics.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Brian Sullivan frequently co-invest with?

Venrock Healthcare Capital Partners
North America, California, United States, Palo Alto
Co-Investments: 1
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Soleus Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1
CC
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Brian Sullivan?

Celcuity

Hamel, Minnesota, United States

Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Post Ipo EquityMay 16, 2022
Amount Raised: $100,000,000